Steris | STE - Operating Profit


Steris reported $285.8M in Operating Profit for its fiscal quarter ending in June of 2026.





Operating Profit Change Date
3M USD 1.56B 57M Sep/2026
Accuray USD 4.71M 6.86M Dec/2024
Baxter International USD 314M 38M Sep/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Boston Scientific USD 1.01B 232M Sep/2026
CONMED USD 37.14M 739K Sep/2026
Cooper Companies USD 222M 253M Jun/2026
Dexcom USD 318.3M 63M Jun/2026
Ecolab USD 891.9M 82.9M Sep/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
Fortive USD 235.9M 26M Sep/2026
Getinge SEK 1.35B 268M Jun/2026
Globus Medical USD -45.97M 209.97M Jun/2026
Haemonetics USD 57.46M 5.12M Jun/2026
Idexx Laboratories USD 425.57M 62.98M Jun/2026
Inogen USD -7.79M 728K Sep/2024
Insulet USD 129.7M 7.7M Jun/2026
Integra LifeSciences USD 42.65M 1.36M Sep/2026
Intuitive Surgical USD 1.05B 69.9M Sep/2026
J&J USD 6.47B 1B Sep/2026
Olympus JPY 30.07B 3.2B Jun/2026
Orthofix International USD 6.12M 1.91M Dec/2025
Owens Minor USD 814K 28.08M Dec/2025
ResMed USD 454.34M 51.33M Jun/2026
Steris USD 285.8M 32.9M Jun/2026
Stryker USD 1.79B 687M Jun/2026
Tandem Diabetes Care USD -13.79M 3.64M Jun/2026
Teleflex USD 73.07M 36.04M Jun/2026
Thermo Fisher Scientific USD 2.46B 277M Sep/2026
Zimmer Biomet Holdings USD 344.7M 50.4M Jun/2026